procedures in total were completed, 5% less than the number completed in 2015. This is represented by a 3% decrease to 2.02 million experimental procedures, and a 7% decrease to 1.91 million procedures to create or breed geneticallyaltered animals not used in other procedures.
Of the 3600 procedures involving NHPs, 3400 were performed on Old World monkeys (macaques), of which 2866 (84%) were for regulatory purposes: of these 2866 procedures, 2454 (86%) were concerned with toxicity and safety testing, 64 (2%) with efficacy and tolerance testing, and 348 (12%) with blood-based products; 295 procedures involved non-lethal acute and sub-acute testing, and 1680 involved repeated-dose testing.
Legislation on medical products for human use was the justification for 2654 procedures with dogs and 2878 procedures with NHPs. This was despite the increasing recognition among scientists that tests in laboratory animals cannot be used to reliably predict the likelihood of acceptable efficacy and/or unacceptable side-effects in humans, as has been repeatedly discussed in ATLA and elsewhere. This has been clearly shown in our own analysis of an extensive data set of over 3000 drugs for which both animal and human data were available. 2 In relation to anti-cancer drugs, Mak et al. 3 put it like this: "Animal models have not been validated as a necessary step in biomedical research in the scientific literature. Instead, there is a growing awareness of the limitations of animal research and its inability to make reliable predictions for human clinical trials." "The average rate of successful translation from animal models to clinical cancer trials is less than 8%. Animal models are limited in their ability to mimic the extremely complex process of human carcinogenesis, physiology and progression. Therefore the safety and efficacy identified in animal studies is generally not translated to human trials." "Animal studies seem to overestimate by about 30% the likelihood that a treatment will be effective, because negative results are often unpublished. Similarly, little more than a third of highly cited animal research is tested later in human trials. Of the one-third that enter into clinical trials, as little as 8% of drugs pass Phase I successfully."
Editorial Animal Experiments and the Right to Ask Questions About Them Michael Balls
The 2016 Home Office Statistics reveal little about progress in implementing the Three Rs, and the right to question how laboratory animals are used in Great Britain has been challenged Without strong scientific justification, there can be no ethically acceptable or comprehensible reasons for conducting tests in laboratory animals. It is high time that the Home Office, the National Centre for the Replacement, Refinement & Reduction of Animals in Research (NC3Rs) and the pharmaceutical and chemical industries faced up to that and did something about it.
The insuperable problem is that laboratory animals cannot be relevant and reliable models for humans, because of fundamental species differences and human variability. This is another issue that has been repeatedly discussed in ATLA, and it is raised again in a Comment in this issue of the journal. 4 
Report in The Times
The publication of the Annual Statistics always leads to a variety of comments in the media. This year, a deplorable article by an unnamed journalist, Animal labs hit by time-wasting tactic, appeared in The Times. 5 It said that "Animal rights groups are targeting universities and government institutions with time-wasting Freedom of Information (FoI) requests designed to disrupt work on important research, experts have claimed." The "experts" who made the claim comprised, or at least included, Professor Dominic Wells of the Royal Veterinary College, and Professor Roger Lemon, of the Institute of Neurology at University College London.
Professor Wells reportedly said that making FoI requests is "a deliberate tactic to use time" … "that is definitely detracting from research". Professor Lemon said that the tactic "could harm laboratory animals", since "it takes up the time of those people who are specifically charged with looking after animal welfare". The NC3Rs supported the experts, by saying that "it's a distraction", whereas one would have expected its mission to require it to take the lead in asking searching questions.
What is deplorable is that a newspaper, which should be fully aware that FoI requests are a very important way in which citizens and institutions in a democracy can try to find out what is really going on, should so thoughtlessly question the sincerity of those who have legitimate concerns about laboratory animal welfare.
The article also raises the question about the motivation and independence of "experts". Professor Lemon is one of the world's leading proponents of experiments on NHPs, and has received support from the NC3Rs to develop tissue-friendly, stable head implants with reduced risk of infection for neuroscience studies using NHPs. He is well known for promoting the disputed claim that that the development of deep brain stimulation as a treatment for Parkinson's disease patients relied on experiments with NHPs. This was discussed by Beuter in the last issue of ATLA, 6 in a number of Letters to the Editor in previous issues, 7−10 and is the subject of another Letter to the Editor in this issue. 11 Professor Lemon denounced an Open Letter calling for an end to invasive experiments on NHPs, signed by Dame Jane Goodall, Sir David Attenborough and 20 other distinguished and experienced scientists. 12, 13 The Right to Question
In a recent issue of ATLA, Robert Combes and I discussed the formation in 2016 of a Consortium for Public Outreach on Animal Research, 14 and wondered how it would be related to the Concordat on Openness in Animal Research, which, according to the Chair of the Concordat Steering Group (and despite its name), seems to be more concerned with building defences against a possible "future upsurge of suspicion about research involving animals". 15 One of our concerns is that the Home Office seems to see regulatory testing as an activity beyond its control and outside the provisions of the Animals (Scientific Procedures) Act 1986, while applying the legislation much more rigorously to the use of animals in fundamental research. The usual ploy is to say that regulatory testing is required by other legislation, both in Great Britain and in other countries.
The only way to allay our concerns would be to make more information more-readily available, and to allow us to continue to exercise our freedom to ask legitimate questions. Meanwhile, relying on experts with vested interests, and thinly-veiled pro-vivisection propagandist organisations, will do nothing to make animal models more relevant and more reliable -nor will it protect human patients, workers and other citizens from the unfortunate consequences of over-reliance on information derived from these models.
Elsewhere in The Times on 14 July, 16 the Home Office defended the increased use in 2016 of guinea-pigs, dogs and rabbits, and the dramatic increase in tests on household product ingredients, by saying that "the UK has one of the most comprehensive animal welfare systems in the world". The Home Secretary should tell her officials that the oft-repeated reliance on this mantra is simply not good enough and convinces no one.
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